Changes in Uric Acid Levels following Bariatric Surgery Are Not Associated with SLC2A9 Variants in the Swedish Obese Subjects Study

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Sarzynski, Mark A ^a   Jacobson, Peter ^b   Rankinen, Tuomo ^a   Carlsson, Björn ^b   Sjöström, Lars ^b   Bouchard, Claude ^a   Carlsson, Lena M S ^b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER; PROTEIN SLC2A9; UNCLASSIFIED DRUG; URIC ACID;

ADULT; ARTICLE; BARIATRIC SURGERY; CONTROLLED STUDY; DNA SEQUENCE; ETHNIC GROUP; EXON; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDISH; TREATMENT RESPONSE; URIC ACID BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN; TIME FACTORS; URIC ACID;

EID: 84871265603     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051658     Document Type: Article

References (35)

1. Richette P, Bardin T, (2010) Gout. Lancet 375: 318-328.
2. Fang J, Alderman MH, (2000) Serum Uric Acid and Cardiovascular Mortality. JAMA: The Journal of the American Medical Association 283: 2404-2410.
3. Gagliardi AC, Miname MH, Santos RD, (2009) Uric acid: A marker of increased cardiovascular risk. Atherosclerosis 202: 11-17.
4. Emmerson BT, (1996) The management of gout. N Engl J Med 334: 445-451.
5. Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, et al. (1997) Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism 46: 1162-1165.
6. Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S, (1986) Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes 10: 255-264.
7. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, et al. (2006) Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 19: 1055-1062.
8. Choi HK, Atkinson K, Karlson EW, Curhan G, (2005) Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 165: 742-748.
9. Dessein PH, Shipton EA, Stanwix AE, Joffe BI, Ramokgadi J, (2000) Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis 59: 539-543.
10. Heyden S, Borhani NO, Tyroler HA, Schneider KA, Langford HG, et al. (1985) The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension. J Chronic Dis 38: 281-288.
11. Ishizaka N, Ishizaka Y, Toda A, Tani M, Koike K, et al. (2010) Changes in waist circumference and body mass index in relation to changes in serum uric acid in Japanese individuals. J Rheumatol 37: 410-416.
12. Rathmann W, Haastert B, Icks A, Giani G, Roseman JM, (2007) Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study. Eur J Epidemiol 22: 439-445.
13. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML, (2003) Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42: 474-480.
14. Luyckx FH, Scheen AJ, Desaive C, Dewe W, Gielen JE, et al. (1998) Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab 24: 355-361.
15. Serpa Neto A, Rossi FM, Valle LG, Teixeira GK, Rossi M, (2011) Relation of uric acid with components of metabolic syndrome before and after Roux-en-Y gastric bypass in morbidly obese subjects. Arq Bras Endocrinol Metabol 55: 38-45.
16. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, et al. (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351: 2683-2693.
17. Rao DC, Laskarzewski PM, Morrison JA, Khoury P, Kelly K, et al. (1982) The Clinical Lipid Research Clinic Family Study: familial determinants of plasma uric acid. Hum Genet 60: 257-261.
18. Whitfield JB, Martin NG, (1983) Inheritance and alcohol as factors influencing plasma uric acid levels. Acta Genet Med Gemellol (Roma) 32: 117-126.
19. Wilk JB, Djousse L, Borecki I, Atwood LD, Hunt SC, et al. (2000) Segregation analysis of serum uric acid in the NHLBI Family Heart Study. Hum Genet 106: 355-359.
20. Charles BA, Shriner D, Doumatey A, Chen G, Zhou J, et al. (2011) A genome-wide association study of serum uric acid in African Americans. BMC Med Genomics 4: 17.
21. Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, et al. (2008) Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372: 1953-1961.
22. Doring A, Gieger C, Mehta D, Gohlke H, Prokisch H, et al. (2008) SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 40: 430-436.
23. Li S, Sanna S, Maschio A, Busonero F, Usala G, et al. (2007) The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 3: e194.
24. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, et al. (2008) SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 40: 437-442.
25. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, et al. (2008) Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 82: 139-149.
26. Caulfield MJ, Munroe PB, O'Neill D, Witkowska K, Charchar FJ, et al. (2008) SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 5: e197.
27. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, et al. (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 5: e1000504.
28. Brandstatter A, Kiechl S, Kollerits B, Hunt SC, Heid IM, et al. (2008) Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care 31: 1662-1667.
29. Sjostrom L, Larsson B, Backman L, Bengtsson C, Bouchard C, et al. (1992) Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord 16: 465-479.
30. Abecasis GR, Cookson WO, (2000) GOLD-graphical overview of linkage disequilibrium. Bioinformatics 16: 182-183.
31. Abecasis GR, Cherny SS, Cookson WO, Cardon LR, (2002) Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30: 97-101.
32. Nyholt DR, (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74: 765-769.
33. Joost HG, Thorens B, (2001) The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol 18: 247-256.
34. Manolescu AR, Augustin R, Moley K, Cheeseman C, (2007) A highly conserved hydrophobic motif in the exofacial vestibule of fructose transporting SLC2A proteins acts as a critical determinant of their substrate selectivity. Mol Membr Biol 24: 455-463.
35. Quinones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, et al. (1995) Effect of insulin on uric acid excretion in humans. American Journal of Physiology- Endocrinology And Metabolism 268: E1-E5.